Company Profiles

driven by the PitchBook Platform

Zylacta

Zylacta
2004 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$254k LATEST DEAL AMOUNT
$479k TOTAL AMOUNT RAISED
2 INVESTORS
Description

Developer of small molecule therapeutics based on bacterial cell wall peptidoglycan. The company focuses on the discovery and development of peptidoglycan-based products for immunotherapy and also offers methods to develop these hits into drugs via a gene-based technology rooted in the company's expertise in genomics of bacterial peptidoglycan synthesis, maturation and shedding.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
7965 Cessna Avenue
Gaithersburg, MD 20879
United States
+1 (410) 501-5727
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Zylacta’s full profile, request a free trial.

Zylacta Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 21-Feb-2008 $254k $479k Completed Startup
2. Early Stage VC 03-Nov-2006 00000 00000 Completed Startup
1. Grant 26-Sep-2006 $75k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Zylacta Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

Zylacta Executive Team (2)

Name Title Board
Seat
Contact
Info
Robert Shalwitz MD Co-Founder & President
Vladimir Slesarev Ph.D Co-Founder & Advisor